CNBC
1 week ago
Novo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'
Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.
Latest News
Horst Jicha skips bail in $150 million USI Tech crypto fraud case in New York
1 week ago
Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternative
1 week ago
Chinese finance minister hints at increasing the deficit at highly anticipated briefing
1 week ago
Dow jumps 400 points to a record on Friday, S&P 500 closes above 5,800 for the first time: Live updates
1 week ago
Boeing to cut 17,000 jobs as losses deepen during factory strike
1 week ago